Are you Dr. Warrell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6 Kimball Cir
Westfield, NJ 07090Phone+1 908-286-3965Fax+1 908-464-1705
Summary
- Dr. Raymond Warrell Jr., MD is an oncologist in Westfield, New Jersey. He is currently licensed to practice medicine in New York.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1978 - 1979
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1976 - 1978
Maimonides Medical CenterInternship, Internal Medicine, 1975 - 1976
Medical College of Georgia at Augusta UniversityClass of 1975
Certifications & Licensure
NY State Medical License 1977 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1999
Publications & Presentations
PubMed
- 2 citationsReply to 'Arsenic patent keeps drug for rare cancer out of reach for many'.Raymond P Warrell
Nature Medicine. 2007-11-01 - 81 citationsPilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic s...Peter Maslak, S. Chanel, Luis H. Camacho, Steven L. Soignet, Pier Paolo Pandolfi
Leukemia. 2006-02-01 - 36 citationsRandomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.Frédérique Cvitkovic, Jean-Pierre Armand, Michèle Tubiana-Hulin, Jean-Francois Rossi, Raymond P. Warrell
Cancer Journal. 2006-01-01
Grant Support
- Arsenic Trioxide In Hematologic CancersNational Cancer Institute1998
- Arsenic Trioxide In Acute Promyelocytic LeukemiaNational Cancer Institute1997–1998
- Core--Clinical Research Support ProgramNational Cancer Institute1996–1997
- Strategies For Treatment Of Acute Promyelcoytic LeukemiaNational Cancer Institute1994
- Strategies For Treatment Of Acute Promyelcoytic LeukemiNational Cancer Institute1992–1993
- Gallium Nitrate For Treatment Of Bone MetastasesNational Cancer Institute1986–1988
- Control Cancer-Related Hypercalcemia By Gallium NitrateNational Cancer Institute1985–1986
